Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH

Summary

Prospective, multi-center, open-label, single-arm, Phase 3b extension study of macitentan in patients with PAH. To assess the long-term safety of macitentan in patients with pulmonary arterial hypertension (PAH) beyond treatment in the AC-055-310 study.

Timeline

Start

2014-06-23

Primary completion

2018-09-19

Completion

2018-09-19

Drugs

Indications